GB0202637D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0202637D0
GB0202637D0 GB0202637A GB0202637A GB0202637D0 GB 0202637 D0 GB0202637 D0 GB 0202637D0 GB 0202637 A GB0202637 A GB 0202637A GB 0202637 A GB0202637 A GB 0202637A GB 0202637 D0 GB0202637 D0 GB 0202637D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0202637A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0202637A priority Critical patent/GB0202637D0/en
Publication of GB0202637D0 publication Critical patent/GB0202637D0/en
Priority to EP02722463A priority patent/EP1383786B1/en
Priority to KR1020037014199A priority patent/KR100831534B1/en
Priority to IL15822202A priority patent/IL158222A0/en
Priority to BR0209271-9A priority patent/BR0209271A/en
Priority to US10/478,893 priority patent/US7291608B2/en
Priority to SI200230765T priority patent/SI1383786T1/en
Priority to AU2002253342A priority patent/AU2002253342B2/en
Priority to AT02722463T priority patent/ATE411334T1/en
Priority to CA002445839A priority patent/CA2445839A1/en
Priority to ES02722463T priority patent/ES2314052T3/en
Priority to DE60229372T priority patent/DE60229372D1/en
Priority to MYPI20021593A priority patent/MY137522A/en
Priority to EP08157256A priority patent/EP2039700A2/en
Priority to HU0400070A priority patent/HUP0400070A2/en
Priority to CNB028112121A priority patent/CN1302007C/en
Priority to MXPA03009940A priority patent/MXPA03009940A/en
Priority to JP2002585465A priority patent/JP4446661B2/en
Priority to NZ528888A priority patent/NZ528888A/en
Priority to CZ20032958A priority patent/CZ20032958A3/en
Priority to ARP020101587A priority patent/AR033290A1/en
Priority to PCT/GB2002/001971 priority patent/WO2002088167A1/en
Priority to PT02722463T priority patent/PT1383786E/en
Priority to PL02366937A priority patent/PL366937A1/en
Priority to DK02722463T priority patent/DK1383786T3/en
Priority to NO20034708A priority patent/NO326015B1/en
Priority to HK04105110.0A priority patent/HK1062020A1/en
Priority to AU2007201491A priority patent/AU2007201491A1/en
Priority to US11/851,125 priority patent/US20070297989A1/en
Ceased legal-status Critical Current

Links

GB0202637A 2001-04-30 2002-02-05 Novel compounds Ceased GB0202637D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB0202637A GB0202637D0 (en) 2002-02-05 2002-02-05 Novel compounds
DK02722463T DK1383786T3 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17-beta carbothioate ester derivatives of androstan with a cyclic ester group in the 17alpha position
HU0400070A HUP0400070A2 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17 beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17alpha, process for the preparation the compounds and pharmaceutical compositions containing them
MXPA03009940A MXPA03009940A (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha.
CNB028112121A CN1302007C (en) 2001-04-30 2002-04-30 Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
BR0209271-9A BR0209271A (en) 2001-04-30 2002-04-30 Compound, use of a compound pharmaceutical composition, pharmaceutical aerosol formulation, method for treating a human or animal patient with an inflammatory and / or allergic condition, and process for preparing a compound
KR1020037014199A KR100831534B1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
SI200230765T SI1383786T1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002253342A AU2002253342B2 (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives
AT02722463T ATE411334T1 (en) 2001-04-30 2002-04-30 ANTIPHLOGISTIC 7.BETA.-CARBOTHIOATE ESTER DERIVATIVES OF ANDROSTAN WITH A 17.ALPHA.-CYCLIC ESTER GROUP
CA002445839A CA2445839A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
ES02722463T ES2314052T3 (en) 2001-04-30 2002-04-30 ESTER DERIVATIVES OF 17BETA-CARBOTIOATE ANDROSTAN WITH A CYCLIC ESTER GROUP IN THE 17ALFA POSITION.
DE60229372T DE60229372D1 (en) 2001-04-30 2002-04-30 ANTIPHLOGISTIC 7.BETA.-CARBOTHIOATES ESTER DERIVATIVES OF ANDROSTAN WITH A 17.ALPHA CYCLIC ESTER GROUP
JP2002585465A JP4446661B2 (en) 2001-04-30 2002-04-30 Anti-inflammatory, 17β-carbothioate derivative of androstane having a cyclic ester group at the 17α position
EP08157256A EP2039700A2 (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives
EP02722463A EP1383786B1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
IL15822202A IL158222A0 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
US10/478,893 US7291608B2 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
MYPI20021593A MY137522A (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives.
NZ528888A NZ528888A (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
CZ20032958A CZ20032958A3 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
ARP020101587A AR033290A1 (en) 2001-04-30 2002-04-30 ANDROSTANO ANTIINFLAMATORY DERIVATIVES
PCT/GB2002/001971 WO2002088167A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
PT02722463T PT1383786E (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
PL02366937A PL366937A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
NO20034708A NO326015B1 (en) 2001-04-30 2003-10-21 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstan with a cyclic ester group at position 17.alpha and its use and preparation, as well as pharmaceutical composition and aerosol formulation
HK04105110.0A HK1062020A1 (en) 2001-04-30 2004-07-13 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2007201491A AU2007201491A1 (en) 2001-04-30 2007-04-04 Novel anti-inflammatory androstane derivatives
US11/851,125 US20070297989A1 (en) 2001-04-30 2007-09-06 Novel anti-inflammatory androstane derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0202637A GB0202637D0 (en) 2002-02-05 2002-02-05 Novel compounds

Publications (1)

Publication Number Publication Date
GB0202637D0 true GB0202637D0 (en) 2002-03-20

Family

ID=9930432

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0202637A Ceased GB0202637D0 (en) 2001-04-30 2002-02-05 Novel compounds

Country Status (1)

Country Link
GB (1) GB0202637D0 (en)

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0201231D0 (en) Novel compounds
GB0201357D0 (en) Novel compounds
GB0202140D0 (en) Novel compounds
GB0202141D0 (en) Novel compounds
GB0202217D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds
GB0202442D0 (en) Novel compounds
GB0202636D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0200787D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)